<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Jordi Cortés Martínez, Marta Bofill Roig and Guadalupe Gómez Melis" />

<meta name="date" content="2025-03-04" />

<title>CompAREdesign: Time-to-event endpoints</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { display: inline-block; text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">CompAREdesign: Time-to-event endpoints</h1>
<h4 class="author">Jordi Cortés Martínez, Marta Bofill Roig and
Guadalupe Gómez Melis</h4>
<h4 class="date">2025-03-04</h4>



<p><code>CompAREdesign</code> R package allows the researchers to design
a randomized clinical trial with a composite endpoint as the primary
endpoint based solely on the information relative to its components.</p>
<div id="case-study-zodiac-trial" class="section level2">
<h2>Case study: ZODIAC Trial</h2>
<p>This example is based on the data from the <a href="https://doi.org/10.1016/S1470-2045(10)70132-7">ZODIAC trial</a>
[1]. ZODIAC was a multinational, randomised, double-blind, phase 3 study
of vandetanib plus docetaxel (Sanofi - Aventis, Paris, France) versus
placebo plus docetaxel in patients with locally advanced or metastatic
NCSLC after progression following platinum-based first-line
chemotherapy. The recent approval and increasing use of pemetrexed as
first-line therapy in NSCLC suggest a continuing role for docetaxel as
second-line therapy.</p>
<p>We can use the information of this study to plan a new similar
trial.</p>
<div id="input-parameters" class="section level3">
<h3>Input Parameters</h3>
<p>First of all, the information for the components of the composite
endpoint should be defined based on the information obtained from the
ZODIAC trial.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="do">## Probabilities of observing the event in control arm during follow-up</span></span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a>p0_e1 <span class="ot">&lt;-</span> <span class="fl">0.59</span>   <span class="co"># Death</span></span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a>p0_e2 <span class="ot">&lt;-</span> <span class="fl">0.74</span>   <span class="co"># Disease Progression  </span></span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a></span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a><span class="do">## Effect size (Cause specific hazard ratios) for each endpoint</span></span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a>HR_e1 <span class="ot">&lt;-</span> <span class="fl">0.91</span>   <span class="co"># Death</span></span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a>HR_e2 <span class="ot">&lt;-</span> <span class="fl">0.77</span>   <span class="co"># Disease Progression</span></span>
<span id="cb1-8"><a href="#cb1-8" tabindex="-1"></a></span>
<span id="cb1-9"><a href="#cb1-9" tabindex="-1"></a><span class="do">## Hazard rates over time</span></span>
<span id="cb1-10"><a href="#cb1-10" tabindex="-1"></a>beta_e1 <span class="ot">&lt;-</span> <span class="dv">2</span>    <span class="co"># Death --&gt; Increasing risk over time</span></span>
<span id="cb1-11"><a href="#cb1-11" tabindex="-1"></a>beta_e2 <span class="ot">&lt;-</span> <span class="dv">1</span>    <span class="co"># Disease Progression --&gt; Constant risk over time</span></span>
<span id="cb1-12"><a href="#cb1-12" tabindex="-1"></a></span>
<span id="cb1-13"><a href="#cb1-13" tabindex="-1"></a><span class="do">## Correlation</span></span>
<span id="cb1-14"><a href="#cb1-14" tabindex="-1"></a>rho      <span class="ot">&lt;-</span> <span class="fl">0.1</span>        <span class="co"># Correlation between components</span></span>
<span id="cb1-15"><a href="#cb1-15" tabindex="-1"></a>rho_type <span class="ot">&lt;-</span> <span class="st">&#39;Spearman&#39;</span> <span class="co"># Type of correlation measure</span></span>
<span id="cb1-16"><a href="#cb1-16" tabindex="-1"></a>copula   <span class="ot">&lt;-</span> <span class="st">&#39;Frank&#39;</span>    <span class="co"># Copula used to get the joint distribution</span></span>
<span id="cb1-17"><a href="#cb1-17" tabindex="-1"></a></span>
<span id="cb1-18"><a href="#cb1-18" tabindex="-1"></a><span class="do">## Additional parameter</span></span>
<span id="cb1-19"><a href="#cb1-19" tabindex="-1"></a>case  <span class="ot">&lt;-</span> <span class="dv">3</span>  <span class="co"># 1: No deaths;                  2: Death is the secondary event; </span></span>
<span id="cb1-20"><a href="#cb1-20" tabindex="-1"></a>            <span class="co"># 3: Death is the primary event; 4: Both events are death by different causes</span></span></code></pre></div>
<p>We set <code>case = 3</code> because Death is the primary event:</p>
<ul>
<li><p><strong>Endpoint 1:</strong> Death</p></li>
<li><p><strong>Endpoint 2:</strong> Disease progression</p></li>
</ul>
<p>The meaning of all the parameters are described in the following
table:</p>
<table>
<colgroup>
<col width="16%" />
<col width="83%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Parameter</th>
<th align="left">Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">p0_e1</td>
<td align="left">Probability of observing event 1 in control arm during
follow-up</td>
</tr>
<tr class="even">
<td align="left">p0_e2</td>
<td align="left">Probability of observing event 2 in control arm during
follow-up</td>
</tr>
<tr class="odd">
<td align="left">HR_e1</td>
<td align="left">Effect size (Cause specific hazard ratios) for endpoint
1</td>
</tr>
<tr class="even">
<td align="left">HR_e2</td>
<td align="left">Effect size (Cause specific hazard ratios) for endpoint
2</td>
</tr>
<tr class="odd">
<td align="left">beta_e1</td>
<td align="left">Hazard rate over time for endpoint 1 (&gt;1: Increasing
risk over time)</td>
</tr>
<tr class="even">
<td align="left">beta_e2</td>
<td align="left">Hazard rate over time for endpoint 2 (=1: Constant risk
over time)</td>
</tr>
<tr class="odd">
<td align="left">rho</td>
<td align="left">Correlation between components</td>
</tr>
<tr class="even">
<td align="left">rho_type</td>
<td align="left">Type of the correlation measure</td>
</tr>
<tr class="odd">
<td align="left">copula</td>
<td align="left">Copula used to get the joint distribution</td>
</tr>
<tr class="even">
<td align="left">case</td>
<td align="left"><p>Additional parameter:</p>
<ol style="list-style-type: decimal">
<li><p>No deaths</p></li>
<li><p>Death is the secondary event</p></li>
<li><p>Death is the primary event;</p></li>
<li><p>Both events are death by different causes</p></li>
</ol></td>
</tr>
</tbody>
</table>
</div>
<div id="are-asymptotic-relatively-efficiency" class="section level3">
<h3>ARE: Asymptotic Relatively Efficiency</h3>
<p>We are considering probabilities in the control group of
<strong>0.59</strong> and <strong>0.74</strong>, with treatment effects
given by Hazard Ratios of <strong>0.91</strong> and
<strong>0.77</strong> for Endpoints 1 and 2, respectively. If the
correlation between the times of both components is low (e.g.,
<strong>0.1</strong>), the Asymptotic Relative Efficiency (ARE) is
<strong>8.79</strong>.</p>
<p>Since the <strong>ARE is greater than 1</strong>, it is recommended
to use the composite endpoint (CE), which combines both endpoints, as
the primary endpoint of the trial. In other words, for a given
significance level and power, the number of required events needed to
attain the same power would be <strong>8.79 times higher</strong> if
Endpoint 1 were used instead of CE.</p>
<p><strong>In this case if we are not sure about the value of the
correlation between</strong> <strong>components, it is not a problem
because using the CE as the primary endpoint</strong> <strong>results in
a more statistically efficient trial design regardless of the</strong>
<strong>correlation ρ because ARE(ρ) &gt; 1.</strong></p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a><span class="fu">ARE_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>        <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>        <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>        <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>        <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case,</span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>        <span class="at">plot_print =</span> <span class="cn">TRUE</span>) </span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
<pre><code>## [1] 8.791</code></pre>
</div>
<div id="effect-size-of-the-composite-endpoint" class="section level3">
<h3>Effect size of the Composite Endpoint</h3>
<p>The function <code>effectsize_tte</code> provides several summary
measures of the treatment effect:</p>
<ul>
<li><code>gAHR</code> (<strong>Geometric Average Hazard
Ratio</strong>)</li>
<li><code>AHR</code> (<strong>Geometric Average Hazard
Ratio</strong>)</li>
<li><code>RMST Ratio</code> (<strong>Restricted Mean Survival Time
Ratio</strong>)</li>
<li><code>Median Ratio</code> (<strong>Median survival time
ratio</strong>)</li>
</ul>
<p>In addition, several measures of the behavior within each group are
provided:</p>
<ul>
<li>RMST (<strong>Restricted Mean Survival Time</strong>)</li>
<li>Median (<strong>Median survival time</strong>)</li>
<li>Prob. E1 (<strong>Probability of observing endpoint 1</strong>)</li>
<li>Prob. E2 (<strong>Probability of observing endpoint 2</strong>)</li>
<li>Prob. CE (<strong>Probability of observing composite
endpoint</strong>)</li>
</ul>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a><span class="fu">effectsize_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>               <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a>               <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a>               <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a>               <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case,</span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a>               <span class="at">plot_print =</span> <span class="cn">TRUE</span>) </span></code></pre></div>
<pre><code>##  Effect measure Effect value | Group measure Reference Treated
##  -------------- ------------ | ------------- --------- -------
##  gAHR           0.8016       |                                
##  AHR            0.8016       |                                
##  RMST ratio     1.1633       | RMST          0.3918    0.4558 
##  Median ratio   1.2321       | Median        0.3212    0.3958 
##                              | Prob. E1      0.5900    0.5557 
##                              | Prob. E2      0.7400    0.7125 
##                              | Prob. CE      0.9300    0.8847</code></pre>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
<p>In the figure above, a slight increase in the HR of the CE is
observed over time.</p>
</div>
<div id="sample-size" class="section level3">
<h3>Sample size</h3>
<p><code>samplesize_tte</code> provides the required number of patients
for the trial using the CE as the primary endpoint as well as the sample
size for each component. In our case study, the sample size using the CE
would be <strong>1118</strong>.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a><span class="fu">samplesize_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a>               <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a>               <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a>               <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a>               <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case, </span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a>               <span class="at">alpha   =</span> <span class="fl">0.025</span>    , <span class="at">power    =</span> <span class="fl">0.90</span>,</span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a>               <span class="at">ss_formula =</span> <span class="st">&#39;schoenfeld&#39;</span>, </span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a>               <span class="at">plot_print =</span> <span class="cn">TRUE</span>) </span></code></pre></div>
<pre><code>##  Endpoint           Total sample size
##  --------           -----------------
##  Endpoint 1         9744             
##  Endpoint 2         1002             
##  Composite endpoint 1120</code></pre>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
<p>The required sample size for a trial with the composite endpoint (CE)
as the primary endpoint depends on the correlation ρ. In general, as the
correlation increases, the sample size also increases. The observed
reduction in sample size for high correlations occurs because, if the
proportion of observed events is kept constant, events in the second
component must almost entirely occur before the end of the follow-up
period. This is necessary to prevent them from being unobserved due to
the occurrence of the first competitive event.</p>
</div>
<div id="influence-of-hazards-rates-over-time-on-the-effect-size" class="section level3">
<h3>Influence of hazards rates over time on the effect size</h3>
<p>The impact of hazard rate behavior over time on the treatment effect
can be analyzed using the function <code>effectsize_tte</code>. The
parameters <code>beta_1</code> (<span class="math inline">\(\beta_1\)</span>) and <code>beta_2</code> (<span class="math inline">\(\beta_2\)</span>) represent the shape parameters
of the Weibull marginal distributions for each component. A value of
<span class="math inline">\(\beta_i &gt; 1\)</span> indicates an
increasing risk over time, while <span class="math inline">\(\beta_i
&lt; 1\)</span> represents a decreasing risk, and <span class="math inline">\(\beta_i = 1\)</span> corresponds to a constant
risk over time.</p>
<p>To examine how this parameter influences the treatment effect of the
CE, the HR of the CE is plotted over time. When both risks are constant,
the HR is almost constant, while when there is an increasing risk of
disease progression over time, the HR decreases over time.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a><span class="do">## Hazards&#39; rates over time Scenario 1</span></span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a>beta_e1 <span class="ot">&lt;-</span> <span class="dv">1</span>    <span class="co"># Death               --&gt; CONSTANT over time</span></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a>beta_e2 <span class="ot">&lt;-</span> <span class="dv">2</span>    <span class="co"># Disease Progression --&gt; INCREASE over time</span></span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a><span class="fu">effectsize_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a>               <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a>               <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a>               <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a>               <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case, </span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a>               <span class="at">plot_print =</span> <span class="cn">TRUE</span>) </span></code></pre></div>
<pre><code>##  Effect measure Effect value | Group measure Reference Treated
##  -------------- ------------ | ------------- --------- -------
##  gAHR           0.8046       |                                
##  AHR            0.8046       |                                
##  RMST ratio     1.1310       | RMST          0.3070    0.3472 
##  Median ratio   1.1310       | Median        0.2820    0.3190 
##                              | Prob. E1      0.5900    0.5557 
##                              | Prob. E2      0.7400    0.7381 
##                              | Prob. CE      0.9986    0.9943</code></pre>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a><span class="do">## Hazards&#39; rates over time Scenario 2</span></span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a>beta_e1 <span class="ot">&lt;-</span> <span class="dv">1</span>    <span class="co"># Death               --&gt; CONSTANT over time</span></span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a>beta_e2 <span class="ot">&lt;-</span> <span class="dv">1</span>    <span class="co"># Disease Progression --&gt; CONSTANT over time</span></span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a><span class="fu">effectsize_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a>               <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a>               <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a>               <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a>               <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case, </span>
<span id="cb10-9"><a href="#cb10-9" tabindex="-1"></a>               <span class="at">plot_print =</span> <span class="cn">TRUE</span>) </span></code></pre></div>
<pre><code>##  Effect measure Effect value | Group measure Reference Treated
##  -------------- ------------ | ------------- --------- -------
##  gAHR           0.8039       |                                
##  AHR            0.8039       |                                
##  RMST ratio     1.2055       | RMST          0.2804    0.3380 
##  Median ratio   1.2454       | Median        0.1990    0.2478 
##                              | Prob. E1      0.5900    0.5557 
##                              | Prob. E2      0.7400    0.7332 
##                              | Prob. CE      0.9676    0.9360</code></pre>
<p><img role="img" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAAEgCAMAAAAjXV6yAAAAtFBMVEUAAAAAADoAAGYAAIsAOpAAZrYzMzM6AAA6ADo6kNtNTU1NTW5NTY5NbqtNjshmAABmtv9uTU1uTW5uTY5ubo5ubqtuq8huq+SOTU2OTW6OTY6Obk2ObquOyP+QOgCQtpCQ2/+rbk2rbm6rbo6rjk2ryKur5OSr5P+2ZgC2kDq2///Ijk3I///bkDrbkJDb///kq27k///r6+v/tmb/yI7/25D/5Kv//7b//8j//9v//+T///8UpTICAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAHAElEQVR4nO2dDV/TVhhHq9MJZQ7d5nBu4MteYAITpKCQ7/+9lqQvuSEl54Y25dae/89fqcdLTQ5PbtKWp3eQmdYMHnoDUo+CIAqCKAiiIIiCIPcW9Plz/mdOvhWqIKAKAqogoAoCqiCgCgKqIKARgr6+Hj4/L+9dvRz+cBICBeW5eb+fnf04NpXfe35eAQWVWt6cZFc/nxQF9Oo8+/rbYQUUlFVaqnsV+D7Pnd/3jeVuQaPnUx/lIbZzWIEiqfyk+6IsqCqYYpL+9UNQQQoqUp9y8r85B9Vz835vehbLyya/VwEFjYumvOwpamY0LC+AvA7qklR2pC+qIKAKAqogoAoCqiCgCgKqIKAKAqogoAoCqiCgCgKqIKAKAqogoAoCqiCgCgKqIKALC9qUWEF3UAUBVRBQBQFVEFAFAVUQUAUBVRBQBQFVEFAFAVUQUAUBVRBQBQFVEFAFAVUQUAUBVRBQBQFVENAIQY2m3rPhsPyqoDJBU2/RDpW7Ot63gsICqjf1vjm5+XAY/HMqO9IXZUFVB+akgvJDbjgsi8im3iJBD++kte6nw6yqolR+0n1RFhS0hedmRpPZeTYPpbIjfVEWVM1BYT+4gmapengnFVR4uvnT03xVQmFT785heR20MzuRpbIjfdEIQe1JZUf6ogoCqiCgCgKqIKAKAqogoAoCqiCgCgKqIKAKAqogoAoCqiCgCgKqIKAKAqogoAoCqiCgCwvalFhBd1AFAVUQUAUBbQj6svsiyy4ef5zcKEhB7VRBQBUEVEFAFQRUQUDnCBpMoyAvFJkqCOgcQeUsdH3w5JOC5gq6fLZdfj2KmoI2UNDR09t3FJTdPs2X8TS/XEHfYZLZ6S60Iej6YHty7zRqms4fhNXMlZWaivm0ISg7nRROZQoE3cdP3VUaKubTpqDs6NG7rDjU4s7zlSD6DzuWVbqC8hN9/jyjtBQpqPtmxLhKV9Ct9LyUccfCSk9Qo+u5t6WMWVWe9AQ1up5XsYxolKugvB5SUKPredVLGcfLmhZZH+nQ9fygSxl3tjXHX6dtaBP0X3lB1Oh6Tmop4yUIa5c5R9DRYFA8Tf2yO75ibHQ9p76Ucd+C8ivp4iL6YjAYPylrdD2v+VLGiwoqn2FcPPl3MLuQbnQ9b/ZSxuWz+fxaOuqJ2AYLivWzqYK2Ip+JKUhBCmqncwT5zmpIG4K6JpUd6YsqCGhDkIdYnc6voLg3NBSkIAUhVRBQBQFVEFAFAW0I8jqoTudXUIeksiN9UQUBVRBQBQFdWNCmxAq6gyoIqIKAKgiogoAqCKiCgCoIqIKAKgiogoAqCKiCgCoIqIKAKgiogoAqCKiCgCoIqIKAKgiogoBGCJo19xRrPBdL0LrWcy31JueRaz03CihsMCxaMV3ruZ5ai2pRSq71XE/Y5Fx+da3nesIKGs1aMV3KeJZwDjrem1IFzRI0OY8PLNd6vl1Cs67nyZHmWs9dksqO9EUVBFRBQBUEVEFAFQRUQUAVBFRBQBUEVEFAFQRUQUAVBFRBQBUEVEFAFQRUQUAVBHRhQZsSK+gOqiCgCgKqIKAKAqogoAoCqiCgCgKqIKAKAqogoAoCqiCgCgKqIKAKAqogoAoCqiCgCgKqIKAKAhohqNHUu9lL+DXSaOrtbSnjJCkLajT1pr6M6HIpC2o09a56KeM00qGp90GXMk68gsqm3qSWMu6dsqBGU69zUD2Npt41X8q4r+ugoKnX66AuSWVH+qIKAqogoAoCqiCgCwvKn3BsxFgFwVgFwVgFwVh/0x6iIIiCIAqCKAhyX0G1lz5ihl29nHxKZdRDFu+gxI29eR98sBpvw+yzaFtTvS54X0H1t4AihhUvKRWfVBn5kGftMoOxx/vBpzzyNpzF/FhHgcd7Cqq//BoxbFRs4nHbXocPefXL762CqrHFvdhtKF9Ux/H5Zu78vXAF1V/AjxzW/g3B2JsP/7QfYtXYq1d/wSFWjY2uoCUcYvW3gOKGFa9px40924M5qBp79XK/VBD1uJET5zIE3aOCvr5u9VOrinMQVBsbXZnFHDiKmqUXF9R5Dip/1JFjx78s0aYzmIP+IEHBPBhX9tlyzmJ7cWex6TD0U39IqKBg7DEdYsE2rLCCul0H5f/f9FdoYsZmsddB5VtSr+napho7GtI10yRLELQxURBEQRAFQRQEURAkUUHXB4Nxnl5uvXvQLUlUUJGHVjOOgiDJC8pvL7fePhsMti/zmxfjo+/xx5VtxVoIevbkU3Y6KG4ef7w+eJplp/n9FWU9BOWFM77ZendRVM+X3Rer2oq1EFTcmd6cjs9u26vaivUTtLqjq8zaCbp4tNpz29oJuj7IS2iFltZOUHmaX2EVJSwojSgIoiCIgiAKgigIoiCIgiAKgigI8j8GtOMUkvFn8wAAAABJRU5ErkJggg==" /><!-- --></p>
</div>
<div id="summary-plots" class="section level3">
<h3>Summary plots</h3>
<p><code>plot_tte</code> returns all the relevant plots for the trial
design if <code>summary=TRUE</code>.</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb12-1"><a href="#cb12-1" tabindex="-1"></a><span class="fu">plot_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb12-2"><a href="#cb12-2" tabindex="-1"></a>         <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb12-3"><a href="#cb12-3" tabindex="-1"></a>         <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb12-4"><a href="#cb12-4" tabindex="-1"></a>         <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb12-5"><a href="#cb12-5" tabindex="-1"></a>         <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case, </span>
<span id="cb12-6"><a href="#cb12-6" tabindex="-1"></a>         <span class="at">summary =</span> <span class="cn">TRUE</span>) </span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
<p>If <code>summary=FALSE</code>, you can select the plot to generate
among different options (<code>survival</code>, <code>effect</code>,
<code>ARE</code>, or <code>samplesize</code>) and further customize it
as needed.</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" tabindex="-1"></a><span class="fu">plot_tte</span>(<span class="at">p0_e1   =</span> p0_e1    , <span class="at">p0_e2    =</span> p0_e2, </span>
<span id="cb13-2"><a href="#cb13-2" tabindex="-1"></a>         <span class="at">HR_e1   =</span> HR_e1    , <span class="at">HR_e2    =</span> HR_e2, </span>
<span id="cb13-3"><a href="#cb13-3" tabindex="-1"></a>         <span class="at">beta_e1 =</span> beta_e1  , <span class="at">beta_e2  =</span> beta_e2,  </span>
<span id="cb13-4"><a href="#cb13-4" tabindex="-1"></a>         <span class="at">rho     =</span> rho      , <span class="at">rho_type =</span> rho_type, </span>
<span id="cb13-5"><a href="#cb13-5" tabindex="-1"></a>         <span class="at">copula  =</span> copula   , <span class="at">case     =</span> case, </span>
<span id="cb13-6"><a href="#cb13-6" tabindex="-1"></a>         <span class="at">summary =</span> <span class="cn">FALSE</span>    , <span class="at">type     =</span> <span class="st">&#39;ARE&#39;</span>) <span class="sc">+</span> </span>
<span id="cb13-7"><a href="#cb13-7" tabindex="-1"></a>  <span class="fu">ggtitle</span>(<span class="st">&#39;Asymptotic Relative Efficiency&#39;</span>) <span class="sc">+</span> <span class="fu">theme_bw</span>()</span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
</div>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<ol style="list-style-type: decimal">
<li>Herbst RS, Sun Y, Eberhardt WEE, Germonpré P, Saijo N, Zhou C et
al. Vandetanib plus docetaxel versus docetaxel as second-line treatment
for patients with advanced non-small-cell lung cancer (ZODIAC): a
double-blind, randomised, phase 3 trial. Lancet Oncol.
2010;11(7):619–26.</li>
</ol>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
